Browsing by Subject
Showing results 49 to 68 of 276
< previous
next >
- Antigen spreading; apoptosis; autoimmunity; haemoglobin; systemic lupus erythematosus. 1
- Antioxidants; Bisphenol A; Brain; GFAP; Oxidative stress; α-Lipoic acid. 1
- AP-1 transcription factor; Bloom helicase; ChIP-seq; Fbw7α; RecQ helicase; SCF(Fbw7) complex; adaptor functions; c-Jun; c-Jun targets; mutants. 1
- Apoptosis; Cytotoxicity; Dihydroartemisinin; Hyaluronic acid; Nanoparticle 1
- APP/PS1 mice; Alzheimer's disease; Biochemistry; Brain insulin resistance; Cognition; Gamma radiation; Molecular biology; Neurology; Neuroscience; Radiology. 1
- ARL6IP5 (ADP-ribosylation-like factor 6 interacting protein 5); Parkinson’s disease (PD); SH-SY5Y cells; autophagy; neurodegeneration; α-synuclein 1
- Arylimidamide-Azole Synergy in Leishmania donovani 1
- ATM kinase; Akt; DNA damage; Mycobacterium tuberculosis; SecA2; infectious disease; microbiology; secretome 2
- autoimmunity; autoreactivity; human chorionic gonadotropin; lupus; systemic lupus erythematosus. 1
- Autologous cell therapy; Differentiation; HBsAg-NAT positive blood; Hepatectomy; Hepatocyte-like cells; c-MET signaling. 1
- Autophagy; evolution; functional diversity; GABARAP; LC3; molecular dynamics; non-covalent interactions; orthologs 1
- Autophagy; GABARAP; LC3; evolution; functional diversity; molecular dynamics; non-covalent interactions; orthologs. 1
- Autophagy; host-directed therapies; macrophage targeting; microparticles; pulmonary drug delivery; tuberculosis 1
- Axonal damage; Bisphenol-A; Demyelination; Inflammation; Multiple sclerosis; Neurotoxicity 1
- Ayurgenomics; Ayurveda; Genome-wide association study; P4 medicine; Rheumatoid arthritis. 2
- B cell help; B cell survival; Mycobacterium tuberculosis; SARS-CoV-2; SCGF/CLEC11A; T-B cocultures; correlates of protection. 1
- B cells; CD4+ T cells; human coronavirus; neutralizing antibody; pre-existing immunity 1
- B-cells; RNA-seq; T-cells; metabolic differences; ribo-seq 1
- Bacterial host; High yield; Mpro; Mpro inhibitors; RIL; SARS-CoV-2. 1
- Bacterial immunotherapy; Chitosan nanoparticles; MIP; Paclitaxel nanoparticles; Tumor targeted delivery. 2